# Effectiveness of Low-Dose Theophylline for the Management of Biomass-Associated COPD

> **NCT03984188** · PHASE3 · COMPLETED · sponsor: **University of Miami** · enrollment: 100 (actual)

## Conditions studied

- COPD
- COPD Exacerbation
- COPD Exacerbation Acute
- Pollution Related Respiratory Disorder
- Pollution; Exposure

## Interventions

- **DRUG:** Theophylline ER
- **DRUG:** Placebo oral tablet
- **OTHER:** Standard of Care Treatment

## Key facts

- **NCT ID:** NCT03984188
- **Lead sponsor:** University of Miami
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-02-23
- **Primary completion:** 2023-10-17
- **Final completion:** 2023-12-15
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2024-11-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03984188

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03984188, "Effectiveness of Low-Dose Theophylline for the Management of Biomass-Associated COPD". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03984188. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*